Rare diseases
Investigational molecules
Locations
Wilhelm-Wagenfeld-Strasse 20, Schwabing-Freimann, 80807 Munich, Germany
Ketabon GmbH focuses on depression research through clinical work centred on ketamine-based antidepressant strategies, with interest in treatments designed to address mood disorders.
The sponsor’s research activity is directed toward orally administered ketamine formulations and comparative evaluation against established intranasal esketamine in the context of antidepressant treatment.
Ketabon GmbH runs clinical trials in conditions such as Major depression, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
